LPA2 antagonist 1
LPA2 antagonist 1 is a LPA2 antagonist with an IC50 of 17 nM.
Product Specifications
CAS Number
[1017606-66-4]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
LPL Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/LPA2-antagonist-1.html
Purity
98.63
Solubility
DMF : ≥ 100 mg/mL|DMSO : ≥ 100 mg/mL
Smiles
ClC1=C(Cl)C=C(S(=O)(N2CCN(C[C@@H](NC3=NC=NC4=C3SC=C4C)C)CC2)=O)C=C1
Molecular Formula
C20H23Cl2N5O2S2
Molecular Weight
500.46
Precautions
H302, H315, H319, H335
References & Citations
[1]Beck HP, et al. Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agents. Bioorg Med Chem Lett. 2008 Feb 1;18 (3) :1037-41.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15115935 1 Vial
Lentiviral human PPP3CA shRNA (UAS) - Lentiviral human PPP3CA shRNA (UAS, iRFP) (100)
Ask
View Details 
